NORTHERN TRUST CORP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$3,974,122
+16.0%
183,902
+3.9%
0.00%0.0%
Q3 2022$3,427,000
-4.9%
177,018
-2.4%
0.00%0.0%
Q2 2022$3,603,000
-34.6%
181,432
-1.7%
0.00%0.0%
Q1 2022$5,506,000
+24.1%
184,577
-3.1%
0.00%0.0%
Q4 2021$4,436,000
-27.1%
190,445
-2.3%
0.00%0.0%
Q3 2021$6,082,000
-13.1%
194,931
-2.0%
0.00%0.0%
Q2 2021$6,999,000
-3.8%
198,958
-3.6%
0.00%0.0%
Q1 2021$7,274,000
-14.3%
206,367
-8.8%
0.00%
-50.0%
Q4 2020$8,489,000
+30.0%
226,339
+15.7%
0.00%
+100.0%
Q3 2020$6,529,000
+24.4%
195,680
-1.2%
0.00%0.0%
Q2 2020$5,248,000
+82.6%
198,105
+12.8%
0.00%0.0%
Q1 2020$2,874,000
-24.5%
175,604
+17.3%
0.00%0.0%
Q4 2019$3,805,000
+27.1%
149,691
+0.0%
0.00%0.0%
Q3 2019$2,993,000
-22.6%
149,649
+24.8%
0.00%0.0%
Q2 2019$3,866,000
+2.4%
119,893
+2.2%
0.00%0.0%
Q1 2019$3,777,000
+35.4%
117,262
+3.1%
0.00%0.0%
Q4 2018$2,789,000
-25.6%
113,693
-0.0%
0.00%0.0%
Q3 2018$3,749,000
+5.8%
113,719
+13.9%
0.00%0.0%
Q2 2018$3,544,000
+590.8%
99,819
+533.1%
0.00%
Q1 2018$513,000
+103.6%
15,766
+60.3%
0.00%
Q4 2017$252,000
+23.5%
9,834
-0.5%
0.00%
Q2 2017$204,0009,8860.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders